首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   243442篇
  免费   76630篇
  国内免费   2464篇
耳鼻咽喉   5895篇
儿科学   9286篇
妇产科学   4182篇
基础医学   18598篇
口腔科学   10630篇
临床医学   49980篇
内科学   69800篇
皮肤病学   14330篇
神经病学   27322篇
特种医学   8609篇
外科学   54640篇
综合类   263篇
现状与发展   79篇
一般理论   24篇
预防医学   18474篇
眼科学   5319篇
药学   6488篇
中国医学   1015篇
肿瘤学   17602篇
  2024年   720篇
  2023年   6669篇
  2022年   1317篇
  2021年   4770篇
  2020年   12370篇
  2019年   13248篇
  2018年   17289篇
  2017年   19011篇
  2016年   20428篇
  2015年   20590篇
  2014年   27938篇
  2013年   30278篇
  2012年   9494篇
  2011年   9631篇
  2010年   19464篇
  2009年   20690篇
  2008年   8158篇
  2007年   5373篇
  2006年   8213篇
  2005年   4880篇
  2004年   3999篇
  2003年   2922篇
  2002年   3053篇
  2001年   5204篇
  2000年   4046篇
  1999年   4087篇
  1998年   4489篇
  1997年   4271篇
  1996年   4245篇
  1995年   3921篇
  1994年   2526篇
  1993年   2076篇
  1992年   1796篇
  1991年   1731篇
  1990年   1375篇
  1989年   1463篇
  1988年   1275篇
  1987年   1047篇
  1986年   1070篇
  1985年   882篇
  1984年   699篇
  1983年   691篇
  1982年   629篇
  1981年   508篇
  1980年   413篇
  1979年   336篇
  1978年   379篇
  1977年   455篇
  1975年   312篇
  1972年   320篇
排序方式: 共有10000条查询结果,搜索用时 29 毫秒
1.

Objective

The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.

Data Source

2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.

Study Design

An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.

Data Collection/Extraction Methods

Not applicable.

Principal Findings

Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.

Conclusion

State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation.  相似文献   
2.
3.
4.
5.
6.
7.
8.
9.
10.
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号